Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
SWOG Cancer Research Network
Big Ten Cancer Research Consortium
University of Leeds
Mario Negri Institute for Pharmacological Research
AstraZeneca
AstraZeneca
University of Birmingham
AstraZeneca
AstraZeneca
Assistance Publique Hopitaux De Marseille
Samsung Medical Center